DE60119963D1 - Imidazol derivate, ihre herstellung und ihre verwendung - Google Patents

Imidazol derivate, ihre herstellung und ihre verwendung

Info

Publication number
DE60119963D1
DE60119963D1 DE60119963T DE60119963T DE60119963D1 DE 60119963 D1 DE60119963 D1 DE 60119963D1 DE 60119963 T DE60119963 T DE 60119963T DE 60119963 T DE60119963 T DE 60119963T DE 60119963 D1 DE60119963 D1 DE 60119963D1
Authority
DE
Germany
Prior art keywords
manufacture
imidazole derivatives
imidazole
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60119963T
Other languages
English (en)
Other versions
DE60119963T2 (de
Inventor
Akihiro Tasaka
Takenori Hitaka
Nobuyuki Matsunaga
Masami Kusaka
Mari Adachi
Isao Aoki
Akio Ojida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical Co Ltd filed Critical Takeda Pharmaceutical Co Ltd
Publication of DE60119963D1 publication Critical patent/DE60119963D1/de
Application granted granted Critical
Publication of DE60119963T2 publication Critical patent/DE60119963T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicinal Preparation (AREA)
DE60119963T 2000-11-17 2001-11-16 Imidazol derivate, ihre herstellung und ihre verwendung Expired - Lifetime DE60119963T2 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP2000351780 2000-11-17
JP2000351780 2000-11-17
JP2001247618 2001-08-17
JP2001247618 2001-08-17
JP2001336880 2001-11-01
JP2001336880 2001-11-01
PCT/JP2001/010002 WO2002040484A2 (en) 2000-11-17 2001-11-16 Novel imidazole derivatives, production method thereof and use thereof

Publications (2)

Publication Number Publication Date
DE60119963D1 true DE60119963D1 (de) 2006-06-29
DE60119963T2 DE60119963T2 (de) 2006-10-05

Family

ID=27345219

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60119963T Expired - Lifetime DE60119963T2 (de) 2000-11-17 2001-11-16 Imidazol derivate, ihre herstellung und ihre verwendung

Country Status (27)

Country Link
US (1) US7141598B2 (de)
EP (2) EP1334106B1 (de)
JP (2) JP3753971B2 (de)
KR (3) KR20080002929A (de)
CN (3) CN100572363C (de)
AR (1) AR034854A1 (de)
AT (2) ATE533768T1 (de)
AU (3) AU1429602A (de)
BR (1) BR0115306B1 (de)
CA (1) CA2429133C (de)
CY (1) CY1105423T1 (de)
DE (1) DE60119963T2 (de)
DK (1) DK1334106T3 (de)
ES (1) ES2260303T3 (de)
HK (1) HK1056168A1 (de)
HU (1) HU229408B1 (de)
IL (2) IL155624A0 (de)
MX (1) MXPA03004347A (de)
MY (1) MY134929A (de)
NO (1) NO326366B1 (de)
NZ (1) NZ526387A (de)
PE (1) PE20020596A1 (de)
PL (1) PL204934B1 (de)
PT (1) PT1334106E (de)
SI (1) SI1334106T1 (de)
TW (1) TWI306099B (de)
WO (1) WO2002040484A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2700690C (en) * 2002-01-10 2013-09-10 Takeda Pharmaceutical Company Limited Process for producing reformatsky reagent in stable form
WO2004075890A1 (ja) * 2003-02-26 2004-09-10 Takeda Pharmaceutical Company 安定化されたイミダゾール誘導体含有医薬組成物、イミダゾ－ル誘導体の安定化方法
JP4745616B2 (ja) * 2003-02-26 2011-08-10 武田薬品工業株式会社 安定化されたイミダゾール誘導体含有医薬組成物、イミダゾール誘導体の安定化方法
EP1607092A4 (de) * 2003-03-17 2010-12-15 Takeda Pharmaceutical Zusammensetzungen mit kontrollierter freisetzung
JP4837895B2 (ja) * 2003-03-17 2011-12-14 武田薬品工業株式会社 放出制御組成物
AU2005243240B2 (en) * 2004-05-03 2012-03-15 Janssen Pharmaceutica N.V. Novel indole derivatives as selective androgen receptor modulators (SARMS)
TW200616623A (en) * 2004-05-28 2006-06-01 Speedel Experimenta Ag Organic compounds
EP1854463A4 (de) * 2005-03-03 2011-03-23 Takeda Pharmaceutical Zusammensetzung mit kontrollierter freisetzung
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
AR056888A1 (es) * 2005-12-09 2007-10-31 Speedel Experimenta Ag Derivados de heterociclil imidazol
US7655683B2 (en) * 2006-02-10 2010-02-02 Janssen Pharmaceutica Nv Imidazolopyrazole derivatives useful as selective androgen receptor modulators
AR060225A1 (es) * 2006-03-31 2008-06-04 Speedel Experimenta Ag Proceso para preparar 6,7- dihidro-5h-imidazo (1,5-a) piridin -8- ona
CL2008003198A1 (es) * 2007-10-29 2009-12-18 Takeda Pharmaceuticals Co Composicion farmaceutica que comprende un inhibidor de esteroide c17,20 liasa; y uso para el tratamiento de cancer de prostata independiente de androgenos.
JOP20190231A1 (ar) * 2009-01-15 2017-06-16 Incyte Corp طرق لاصلاح مثبطات انزيم jak و المركبات الوسيطة المتعلقة به
UY33740A (es) * 2010-11-18 2012-05-31 Takeda Pharmaceutical Método para tratar el cáncer de mama y cáncer de ovarios
BR112013022010A2 (pt) 2011-04-01 2016-11-29 Takeda Pharmaceuticals Co preparação sólida, e, método de estabilização de um composto ou um sal do mesmo
MX2013014009A (es) 2011-06-15 2014-03-12 Takeda Pharmaceutical Metodo de produccion de derivados de imidazol.

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4728645A (en) * 1982-12-21 1988-03-01 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridine derivatives and other substituted bicyclic derivatives, useful as aromatase inhibitors
NZ221729A (en) 1986-09-15 1989-07-27 Janssen Pharmaceutica Nv Imidazolyl methyl-substituted benzimidazole derivatives and pharmaceutical compositions
AU606677B2 (en) 1987-04-22 1991-02-14 Merrell Dow Pharmaceuticals Inc. 17 beta -(cyclopropylimino) androst-5-EN-3 beta- Ol and related compounds useful as C17-20 lyase inhibitors
US5057521A (en) * 1988-10-26 1991-10-15 Ciba-Geigy Corporation Use of bicyclic imidazole compounds for the treatment of hyperaldosteronism
US4966898A (en) 1989-08-15 1990-10-30 Merrell Dow Pharmaceuticals Inc. 4-substituted 17β-(cyclopropylamino)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors
JPH06507355A (ja) 1991-03-01 1994-08-25 エレクトロスタティック　テクノロジー　インコーポレーテッド 回路板用薄層板等を製造するための粉体コーティング法
CA2127689A1 (en) 1992-01-27 1993-08-05 Marcel A. C. Janssen Pyrroloimidazolyl and imidazopyridinyl substituted 1h-benzimidazole derivatives as aromatase inhibitors
US5457102A (en) 1994-07-07 1995-10-10 Janssen Pharmaceutica, N.V. Pyrroloimidazolyl and imidazopyridinyl substituted 1H-benzimidazole derivatives
JP2742331B2 (ja) 1992-03-31 1998-04-22 ブリテイツシユ・テクノロジー・グループ・リミテツド 癌治療に有用な１７位置換ステロイド
GB9310635D0 (en) 1993-05-21 1993-07-07 Glaxo Group Ltd Chemical compounds
KR960704852A (ko) 1993-09-30 1996-10-09 오노다 마사요시 아졸 유도체 및 이의 약제학적 조성물 (Azole derivative and pharmaceutical composition thereof)
WO1996014090A1 (en) 1994-11-07 1996-05-17 Janssen Pharmaceutica N.V. Compositions comprising carbazoles and cyclodextrins
AU6015796A (en) 1995-06-14 1997-01-15 Yamanouchi Pharmaceutical Co., Ltd. Fused imidazole derivatives and medicinal composition thereof
ATE231128T1 (de) 1997-02-21 2003-02-15 Takeda Chemical Industries Ltd Verbindungen mit kondensierten ringen, verfahren zu ihrer herstellung und ihre anwendung
NZ501822A (en) 1997-10-02 2001-12-21 Yukijirushi Nyugyo Kabushiki K Therapeutic agents for male and female sex hormone dependent diseases
DE69924717T2 (de) 1998-04-23 2006-03-09 Takeda Pharmaceutical Co. Ltd. Naphthalene derivate ,ihre herstellung und verwendung
PE20010781A1 (es) * 1999-10-22 2001-08-08 Takeda Chemical Industries Ltd Compuestos 1-(1h-imidazol-4-il)-1-(naftil-2-sustituido)etanol, su produccion y utilizacion

Also Published As

Publication number Publication date
EP1681290A2 (de) 2006-07-19
PT1334106E (pt) 2006-08-31
CN1474819A (zh) 2004-02-11
BR0115306A (pt) 2004-02-10
NO326366B1 (no) 2008-11-17
DK1334106T3 (da) 2006-09-18
CN1900079A (zh) 2007-01-24
US20040033935A1 (en) 2004-02-19
KR20080002929A (ko) 2008-01-04
BR0115306B1 (pt) 2013-12-24
AU2002214296C1 (en) 2006-04-13
CY1105423T1 (el) 2010-04-28
ES2260303T3 (es) 2006-11-01
KR100725442B1 (ko) 2007-06-07
HUP0400549A3 (en) 2004-09-28
KR20030048156A (ko) 2003-06-18
HU229408B1 (hu) 2013-12-30
IL155624A (en) 2006-12-31
ATE327237T1 (de) 2006-06-15
EP1334106A2 (de) 2003-08-13
CN1680336A (zh) 2005-10-12
PE20020596A1 (es) 2002-08-13
IL155624A0 (en) 2003-11-23
AU1429602A (en) 2002-05-27
WO2002040484A3 (en) 2002-09-26
EP1681290A3 (de) 2006-07-26
CA2429133C (en) 2009-08-18
AR034854A1 (es) 2004-03-24
CN1329394C (zh) 2007-08-01
JP3753971B2 (ja) 2006-03-08
CN100572363C (zh) 2009-12-23
MXPA03004347A (es) 2004-05-04
NZ526387A (en) 2004-02-27
TWI306099B (en) 2009-02-11
EP1334106B1 (de) 2006-05-24
SI1334106T1 (sl) 2006-10-31
WO2002040484A2 (en) 2002-05-23
NO20032234L (no) 2003-07-16
JP2003201282A (ja) 2003-07-18
AU2005225035B2 (en) 2007-02-22
HK1056168A1 (en) 2004-02-06
AU2005225035A1 (en) 2005-11-10
JP2006045239A (ja) 2006-02-16
HUP0400549A2 (hu) 2004-06-28
PL204934B1 (pl) 2010-02-26
ATE533768T1 (de) 2011-12-15
JP4427496B2 (ja) 2010-03-10
NO20032234D0 (no) 2003-05-16
MY134929A (en) 2008-01-31
KR20050105287A (ko) 2005-11-03
AU2002214296B2 (en) 2005-09-29
PL362766A1 (en) 2004-11-02
KR100809899B1 (ko) 2008-03-10
EP1681290B1 (de) 2011-11-16
DE60119963T2 (de) 2006-10-05
US7141598B2 (en) 2006-11-28
CA2429133A1 (en) 2002-05-23
EP1681290B9 (de) 2013-06-19

Similar Documents

Publication Publication Date Title
ATE284886T1 (de) Benzimidazolderivate, ihre herstellung und therapeutische verwendung
ATE286021T1 (de) Substituierte phenylderivate, ihre herstellung und verwendung
DE60203917D1 (de) Phenylsulfonyl-1,3-dihydro-2h-indol-2-on derivate, deren herstellung und deren therapeutische verwendung
DE60119963D1 (de) Imidazol derivate, ihre herstellung und ihre verwendung
ATE425147T1 (de) Imidazolderivate
ATE424202T1 (de) Substituierte 2-thio-3,5-dicyano-4-phenyl-6- aminopyridine und ihre verwendung
DE60225563D1 (de) 4-amino-6-phenyl-pyrroloä2,3-düpyrimidin derivate
EE200300049A (et) Imidasooli derivaadid
ATE360620T1 (de) Imidazolderivate
ATE539062T1 (de) Bizyklishe verbindung, ihre herstellung und verwendung
DE50207849D1 (de) Substituierte 2-oxy-3,5-dicyano-4-aryl-6-aminopyridine und ihre verwendung
ATE261449T1 (de) Thienopyrimidin verbindungen, ihre herstellung und verwendung
ATE261933T1 (de) Admantan derivate
DE60001307D1 (de) Pyridopyranoazepinderivate, ihre herstellung und therapeutische verwendung
NO20003723D0 (no) Triazol- og imidazolderivater
ATE273962T1 (de) 5-phenyl-pyrimidine derivate
DE60235547D1 (de) En daraus, deren herstellung und verwendung
ATE267201T1 (de) 4-(2-phenylthiazol-5-yl)1,4- diazabicyclo(3.2.2)nonanederivate, ihre herstellung und therapeutische verwendung
ATE357448T1 (de) Benzoxazinonderivative, deren herstellung und verwendung
DE60208044D1 (de) Acylaminothiazolderivate, deren herstellung und deren therapeutische verwendung
ATE242197T1 (de) 3-amino-3-arylpropan-1-ol-derivate, deren herstellung und verwendung
DE60321372D1 (de) 3-phenylpyridoindolderivate, ihre herstellung und verwendung
DE59802922D1 (de) 3-substituierte tetrahydropyridopyrimidinon-derivate, ihre herstellung und verwendung
DE60144456D1 (de) DibenzoÄb,fÜazepin-Derivate und ihre Herstellung
ATE249451T1 (de) Benzofuranderivate, ihre herstellung und verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition